Rancho Santa Fe, CA, United States of America

Philip L Felgner

USPTO Granted Patents = 49 (Patent Applications = 10)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 22

Forward Citations = 5,741(Granted Patents)

Location History:

Los Altos, CA (US) (1990 - 1997)
Palo Alto, CA (US) (2002)
Rancho Sata Fe, CA (US) (2005)
San Diego, CA (US) (1998 - 2008)
Rancho Santa Fe, CA (2015)
Rancho Santa Fe, CA (US) (1993 - 2019)
Rancho Sante Fe, CA (US) (2011 - 2019)
Irvine, CA (US) (2019 - 2021)

Company Filing History:

Gene Therapy Systems, Inc.

patents

4. 5 out of 4,119

Wisconsin Alumni Research Foundation

patents

5. 5 out of 5

Immport Therapeutics, Inc.

patents

6. 3 out of 15,458

University of California

patents

7. 2 out of 1,035

Isis Pharmaceuticals, Inc.

patents

8. 1 out of 59

La Jolla Institute for Allergy and Immunology

patents

9. 1 out of 9

Autonomous Medical Devices Inc.

patents

10. 1 out of 1

Immport Theerapeutics, Inc.

Antigen Discovery, Inc.

patent

13. 1 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

14. 1 out of 1,454

Rutgers, the State University of New Jersey

patents

15. 8 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2021

Loading Chart...

49 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11130994 - Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method (2021-09-28),

2. 10260168 - Microfluidic devices and methods (2019-04-16),

3. 10197577 - Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines (2019-02-05),

4. 10174311 - Compositions and methods for immunodominant antigens (2019-01-08),

5. 10053687 - [object Object] (2018-08-21),

6. 9494586 - [object Object] (2016-11-15),

7. 9297803 - Compositions and methods for immunodominant antigens (2016-03-29),

8. 9182412 - [object Object] (2015-11-10),

9. 8883431 - [object Object] (2014-11-11),

10. 8329418 - [object Object] (2012-12-11),

11. 8247181 - [object Object] (2012-08-21),

12. 8114614 - [object Object] (2012-02-14),

13. 7927818 - [object Object] (2011-04-19),

14. 7470675 - Methods for treating cancer using interferon-ω-expressing polynucleotides (2008-12-30),

15. 7393533 - H3L envelope protein immunization methods and H3L envelope passive protection methods (2008-07-01),

Title: The Innovative Journey of Philip L Felgner

Introduction:

Philip L Felgner, a distinguished inventor hailing from Rancho Santa Fe, CA, has made significant contributions to the field of biotechnology and medical research through his groundbreaking innovations.

Latest Patents:

1. "Patent Title 1" - Patent Number: USXXXXXXX

2. "Patent Title 2" - Patent Number: USXXXXXXX

3. "Patent Title 3" - Patent Number: USXXXXXXX

Career Highlights:

Felgner's illustrious career includes pioneering work in the development of novel drug delivery systems, particularly in the realm of nucleic acid vaccines. His innovative approaches have revolutionized the way vaccines are administered and have paved the way for advancements in personalized medicine.

Collaborations:

Throughout his career, Felgner has collaborated with leading pharmaceutical companies, research institutions, and universities to further his research and bring his inventions to fruition. His collaborative spirit and dedication to scientific advancement have earned him recognition as a trailblazer in the field.

Conclusion:

In conclusion, Philip L Felgner's relentless pursuit of innovation and his commitment to pushing the boundaries of biotechnology have established him as a visionary inventor in the scientific community. His contributions continue to inspire future generations of inventors and researchers in their quest to improve global healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.